Concave Annelated Terpyridines
(KBr): ν = 2934, 1697, 1598, 1471, 1241, 1090 cm–1. 1H NMR C19H13Cl2N3 (354.23): calcd.
C
64.42, H 3.70, N 11.86;
˜
(300 MHz, CDCl3): δ = 7.67 (d, J = 8.0 Hz, 1 H, 4-H), 7.38 (d, J C19H13Cl2N3·0.2 CH2Cl2: calcd. C 62.12, H 3.64, N 11.32; found
= 8.0 Hz, 1 H, 3-H), 7.29 (t, J = 8.4 Hz, 1 H, 4Ј-H), 6.61 (mc, 2 H, C 62.11, H 3.77, N 11.25.
3Ј-H, 5Ј-H), 3.69 (s, 6 H, OCH3), 3.06 (t, J = 6.1 Hz, 2 H, 7-H),
2,12-Bis(2,6-dimethoxyphenyl)-5,6,8,9-tetrahydroquino[8,7-b]-1,10-
2.81 (t, J = 6.1 Hz, 2 H, 5-H), 2.21 (quint, J = 6.4 Hz, 2 H, 6-
phenanthroline (13a): Synthesized according to the general pro-
H) ppm. 13C NMR (125 MHz, CDCl3): δ = 196.6 (s, C-8), 158.3
cedure: 2-(2,6-dimethoxyphenyl)-5,6,7,8-tetrahydro-8-quinolone
(10a; 0.48 g, 1.66 mmol), ammonium acetate (64.0 mg, 0.83 mmol),
Eschenmoser’s salt (155 mg, 0.83 mmol), DMSO (25 mL). Purified
by column chromatography on neutral alumina (activity II–III)
(s, C-2Ј, C-6Ј), 154.3 (s, C-2), 148.1 (s, C-1Ј), 138.9 (s, C-8a), 137.2
(d, C-4), 129.8 (d, C-3, C-4Ј), 118.8 (s, C-4a), 104.2 (d, C-3Ј, C-5Ј),
55.9 (q, CH3), 39.9 (t, C-7), 29.2 (t, C-5), 22.7 (t, C-6) ppm. MS
(ESI): m/z (%) = 306 (100) [M + Na+]. HRMS: calcd. for
eluting with dichloromethane/ethyl acetate (4:1); yield 139 mg
C17H17NO3 283.12085; found 283.12304 (7.7 ppm); calcd. for
1
(25%). IR (KBr): ν = 2928, 1601, 1473, 1430, 1251, 1109 cm–1. H
˜
C1613CH17NO3 284.12421; found 284.12462 (1.4 ppm). C17H17NO3
NMR (500 MHz, CDCl3): δ = 7.55 (d, J = 7.7 Hz, 2 H, 4-H, 10-
H), 7.40 (s, 1 H, 7-H), 7.27 (t, J = 8.3 Hz, 2 H, 4Ј-H, 4ЈЈ-H), 7.22
(d, J = 7.7 Hz, 2 H, 3-H, 11-H), 6.59 (d, J = 8.3 Hz, 4 H, 3Ј-H,
(283.32): calcd. C 72.07, H 6.05, N 4.94; found C 71.90, H 6.23, N
4.94.
2-[2,6-Bis(hex-5-enyloxy)phenyl]-5,6,7,8-tetrahydro-8-quinolone (10b):
[2,6-Bis(hex-5-enyloxy)phenyl]boronic (9b; 1.25 g,
acid[14]
3ЈЈ-H, 5Ј-H, 5ЈЈ-H), 3.66 (s, 12 H, OCH3), 2.99 (m, 8 H, 5-H, 6-H,
8-H, 9-H) ppm. 13C NMR (125 MHz, CDCl3): δ = 158.5 (s, C-2Ј,
C-2ЈЈ, C-6Ј, C-6ЈЈ), 153.3 (s, C-2, C-12), 151.8 (s, C-13a, C-14b),
151.1 (s, C-13b, C-14a), 135.3 (d, C-4, C-10), 135.0 (d, C-7), 133.8
(s, C-6a, C-7a), 131.6 (s, C-4a, C-9a), 129.3 (d, C-4Ј, C-4ЈЈ), 125.9
(d, C-3, C-11), 119.6 (s, C-1Ј, C-1ЈЈ), 104.6 (d, C-3Ј, C-3ЈЈ, C-5Ј, C-
5ЈЈ), 56.3 (q, OCH3), 27.7 (t, C-6, C-8), 27.6 (t, C-5, C-9) ppm. MS
(ESI): m/z (%) = 1115 (4) [2M+], 558 (100) [M + H+]. C35H31N3O4
(557.64): calcd. C 75.38, H 5.60, N 7.54; found C 75.24, H 5.51, N
7.35.
3.93 mmol), tetrakis(triphenylphosphane)palladium(0) (186 mg,
161 μmol), barium hydroxide (390 mg, 2.28 mmol), and water
(15 mL) were added to a solution of 2-chloro-5,6,7,8-tetrahydro-8-
quinolone (8; 584 mg, 3.22 mmol) in 1,2-dimethoxyethane (90 mL).
The reaction mixture was heated to reflux temperature for 48 h.
After addition of water (50 mL) and chloroform (50 mL), the aque-
ous layer was extracted with chloroform (3ϫ50 mL) and the com-
bined organic layer was washed with brine (20 mL). The solvent
was removed in vacuo and the residue was purified by chromatog-
raphy (silica gel; cyclohexane/ethyl acetate, 1:1), yielding 10b
2,12-Bis[2,6-bis(hex-5-enyloxy)phenyl]-5,6,8,9-tetrahydroquino[8,7-
b]-1,10-phenanthroline (13b): Synthesized according to the general
procedure: 2-[2,6-Bis(hex-5-enyloxy)phenyl]-5,6,7,8-tetrahydro-8-
quinolone (10b; 2.02 g, 4.76 mmol), ammonium acetate (185 mg,
2.40 mmol), Eschenmoser’s salt (450 mg, 2.43 mmol), DMSO
(30 mL). Purified by column chromatography on neutral alumina
(activity II–III) eluting with dichloromethane/ethyl acetate (4:1)
and chromatotron on neutral alumina eluting with dichlorometh-
(973 mg, 72%). IR (KBr): ν = 2934, 1697, 1639, 1598, 1471, 1241,
˜
1
1090 cm–1. H NMR (200 MHz, CDCl3): δ = 7.61 (d, J = 8.0 Hz,
1 H, 4-H), 7.37 (d, J = 8.0 Hz, 1 H, 3-H), 7.22 (t, J = 8.3 Hz, 1 H,
4Ј-H), 6.57 (d, J = 8.3 Hz, 2 H, 3Ј-H, 5Ј-H), 5.69 (tdd, J = 6.8,
10.9, 17.8 Hz, 2 H, CH=), 4.96–4.82 (m, 4 H, =CH2), 3.90 (t, J =
6.2 Hz, 4 H, OCH2), 3.04 (t, J = 6.1 Hz, 2 H, 7-H), 2.80 (t, J =
6.1 Hz, 2 H, 5-H), 2.21 (quint, J = 6.4 Hz, 2 H, 6-H), 1.98–1.84 (m,
4 H, =CHCH2), 1.66–1.48 (m, 4 H, OCH2CH2), 1.38–1.22 (m, 4
H, OCH2CH2CH2) ppm. 13C NMR (50 MHz, CDCl3): δ = 196.3
(s, C-8), 157.9 (s, C-2Ј, C-6Ј), 154.4 (s, C-2), 147.8 (s, C-1Ј), 138.8
(d, CH2CH=CH2), 138.5 (s, C-8a), 136.7 (d, C-4), 129.9 (d, C-3),
129.6 (d, C-4Ј), 119.8 (s, C-4a), 114.3 (t, CH2CH=CH2), 105.6 (d,
C-3Ј, C-5Ј), 68.7 (t, OCH2CH2), 39.9 (t, C-7), 33.2 (t,
CH2CH=CH2), 29.2 (t, C-5), 28.8 (t, OCH2CH2), 28.5 (t,
CH2CH2CH2), 22.8 (t, C-6) ppm. MS (ESI): m/z (%) = 861 (17)
[2M + Na+], 442 (16) [M + Na+], 420 (100) [M + H+]. C27H33NO3
(419.56): calcd. C 77.29, H 7.93, N 3.34; found C 77.54, H 8.05, N
3.35.
ane/ethyl acetate (10:1 to 4:1); yield 946 mg (48%). IR (Film): ν =
˜
2928, 1639, 1600, 1244, 1099 cm–1. 1H NMR (500 MHz, CDCl3):
δ = 7.51 (d, J = 7.7 Hz, 2 H, 4-H, 10-H), 7.40 (s, 1 H, 7-H), 7.22
(t, J = 8.3 Hz, 2 H, 4Ј-H, 4ЈЈ-H), 7.19 (d, J = 7.7 Hz, 2 H, 3-H, 11-
H), 6.57 (d, J = 8.3 Hz, 4 H, 3Ј-H, 5Ј-H, 3ЈЈ-H, 5ЈЈ-H), 5.58 (tdd,
J = 6.6, J = 10.3, J = 16.9 Hz, 4 H, CH=), 4.84–4.76 (m, 8 H,
=CH2), 3.87 (t, J = 6.3 Hz, 8 H, OCH2), 2.98 (br. s, 8 H, 5-H, 6-
H, 8-H, 9-H), 1.85–1.79 (m, 8 H, =CHCH2), 1.53–1.45 (m, 8 H,
OCH2CH2), 1.28–1.21 (m, 8 H, OCH2CH2CH2) ppm. 13C NMR
(125 MHz, CDCl3): δ = 157.9 (s, C-2Ј, C-2ЈЈ, C-6Ј, C-6ЈЈ), 153.5 (s,
C-2, C-12), 151.6 (s, C-13a, C-14b), 151.1 (s, C-13b, C-14a), 139.1
(d, CH=), 134.9 (d, C-4, C-7, C-10), 133.8 (s, C-6a, C-7a), 131.6
(s, C-4a, C-9a), 129.2 (d, C-4Ј, C-4ЈЈ), 126.0 (d, C-3, C-11), 120.4
(s, C-1Ј, C-1ЈЈ), 113.9 (t, =CH2), 105.9 (d, C-3Ј, C-3ЈЈ, C-5Ј, C-5ЈЈ),
68.8 (t, OCH2), 33.4 (t, CH2CH=), 28.6 (t, OCH2CH2), 27.9 (t, C-
6, C-8), 27.7 (t, C-5, C-9), 25.2 (t, CH2) ppm. MS (ESI): m/z (%)
= 830 (100) [M + H+]. C55H63N3O4 (830.11): calcd. C 79.58, H
7.65, N 5.06; found C 79.38, H 7.60, N 5.10.
2,12-Dichloro-5,6,8,9-tetrahydroquino[8,7-b]-1,10-phenanthroline (12):
Synthesized according to the general procedure: 2-chloro-5,6,7,8-
tetrahydro-8-quinolone (8; 1.22 g, 6.60 mmol), ammonium acetate
(255 mg, 3.30 mmol), Eschenmoser’s salt (648 mg, 3.50 mmol),
DMSO (50 mL). Purified by column chromatography on neutral
alumina (activity II–III) eluting with dichloromethane/ethyl acetate
(4:1); yield 322 mg (26%). IR (KBr): ν = 2927, 1654, 1543, 1457,
˜
1403 cm–1. H NMR (300 MHz, CDCl3): δ = 7.95 (d, J = 7.9 Hz, 275,276,278,279-Tetrahydro-2,13,15,26-tetraoxa-1,14(1,3,2)-dibenz-
1
2 H, 4-H, 10-H), 7.46 (s, 1 H, 7-H), 7.23 (d, J = 7.9 Hz, 2 H, 3- ena-27(2,12)-{quino[8,7-b]-1,10-phenanthrolina}bicyclo[12.12.1]-
1
H, 11-H), 3.06–2.92 (m, 8 H, 5-H, 6-H, 8-H, 9-H) ppm. H NMR
heptacosaphane-7,20-diene (14): 2,12-Bis-[2,6-bis(hex-5-enyloxy)-
(200 MHz, CD2Cl2): δ = 7.56 (d, J = 7.9 Hz, 2 H, 4-H, 10-H), 7.46 phenyl]-5,6,8,9-tetrahydroquino[8,7-b]-1,10-phenanthroline (13b;
(s, 1 H, 7-H), 7.27 (d, J = 7.9 Hz, 2 H, 3-H, 11-H), 3.03–2.96 (m,
950 mg, 1.14 mmol) was dissolved in dichloromethane (600 mL)
and benzylidenebis(tricyclohexylphosphane)dichlororuthenium
8 H, 5-H, 6-H, 8-H, 9-H) ppm. 13C NMR (50 MHz, CD2Cl2): δ =
152.7 (s, C-2, C-12), 150.5 (s, C-13a, C-14b), 150.1 (s, C-13b, C- (84.0 mg, 102 μmol, 9 mol-%) was added. After stirring for 19 h at
14a), 139.1 (d, C-4, C-10), 136.1 (d, C-7), 135.5 (s, C-6a, C-7a), room temp., the solvent was removed in vacuo and the residue was
133.2 (s, C-4a, C-9a), 124.2 (d, C-3, C-11), 27.6 (t, C-6, C-8), 27.1 filtered two times through neutral alumina (activity II–III) eluting
(t, C-5, C-9) ppm. MS (ESI): m/z (%) = 731 (45) [2M + Na+], 376
(100) [M + Na+]. MS (EI, 70 eV): m/z (%) = 355 (13), 353 (21)
[M+]. MS (CI, isobutane): m/z (%) = 356 (26), 354 (31) [M + H+].
with dichloromethane/ethyl acetate (4:1). Finally, the residue was
purified with a chromatotron (neutral alumina) eluting with dichlo-
romethane/ethyl acetate (10:1 to 4:1); yield 670 mg (74 %). IR
Eur. J. Org. Chem. 2012, 1346–1350
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
1349